Insider sale
AXIM BIOTECHNOLOGIES, INC.
$76.1K
845.01K shares
What this filing means
WILSON-DAVIS & CO., INC. plans to sell 845.01K shares of AXIM BIOTECHNOLOGIES, INC. valued at approximately $76.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/7/2022ACC: 0000107476-22-000007
845.01K
Shares to sell
$76.1K
Approx. market value
845.01K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Debt Conversion
Debt Conversion
8/23/2022
845.01KTotal acquired845.01K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/23/2022 | Debt Conversion Debt Conversion | 845.01K | — |
| Total | 845.01K | ||
Planned & Completed Dispositions1
N/APlanned
Units to sell
845.01K
Market value
$76.1K
9/15/2022
Total
Units
845.01K
Value
$76.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/15/2022 | 845.01K | $76.1K | N/A | Planned |
| Total | 845.01K | $76.1K | ||